Michael E. Abram

6.7k citations
62 papers · 4.9k · 4 hit papers · h-index 32

Impact in

  • Epidemiology top 0.5%
    • Respiratory viral infections research
    • Influenza Virus Research Studies
    • Pneumonia and Respiratory Infections
    • HIV/AIDS drug development and treatment
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • HIV/AIDS drug development and treatment 22
    • SARS-CoV-2 and COVID-19 Research 3
    • Respiratory viral infections research 32
    • Pneumonia and Respiratory Infections 1
    • Influenza Virus Research Studies 1

Michael E. Abram

61 papers receiving 4.7k citations

Michael E. Abram's Hit Papers

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants 2023 · 96 citations
960+1+2Years since publication4008001.2k

Peers

Michael E. Abram
Comparison fields: 5 of 91
  • Epidemiology 3k
  • Infectious Diseases 1.2k
  • Virology 200
  • Emergency Medicine 118
  • Health 88
Replace Stephen Follansbee with:
Stephen Follansbee United States
Anne P. Cross United States
Dirk Schürmann Germany
Mariam Sylla Mali
Richard Hafner United States
Jean‐Luc Meynard France
Beverly E. Sha United States
Işık Somuncu Johansen Denmark
Harold A. Kessler United States
Sonia Stoszek United States
Michael E. Abram relative to Stephen Follansbee United States Stephen Follansbee's profile →
Citations per field
00.5×20×40×60.8×
Stephen Follansbee · 1×
Citations per year

Countries citing papers authored by Michael E. Abram

Since Specialization
Citations

This map shows the geographic impact of Michael E. Abram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Abram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Abram more than expected).

Fields of papers citing papers by Michael E. Abram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Abram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Abram. The network helps show where Michael E. Abram may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael E. Abram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael E. Abram Line = papers co-authored together Michael E. Abram links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
Hit paper breakdown →
20221310
2
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
Hit paper breakdown →
2022742
3 2010202
4 2015174
5
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans
Hit paper breakdown →
2022174
6 2016144
7 2007110
8 2013109
9 2013101
10
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants
Hit paper breakdown →
202396
11 202094
12 202292
13 202185
14 202381
15 202375
16 202372
17 201771
18 202062
19 202259
20 200158

About Michael E. Abram

Michael E. Abram is a scholar working on Infectious Diseases, Epidemiology, Virology, Emergency Medical Services and Statistics and Probability, having authored 62 papers that have together received 4.9k indexed citations. Recurring topics across this work include Respiratory viral infections research (32 papers), HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (7 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Cancer therapeutics and mechanisms (2 papers), Pneumonia and Respiratory Infections (1 paper), Influenza Virus Research Studies (1 paper) and Mental Health and Patient Involvement (1 paper). The work is most often cited by research in Epidemiology (3k citations), Infectious Diseases (1.2k citations), Virology (200 citations), Emergency Medicine (118 citations) and Health (88 citations). Michael E. Abram has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Andrea L. Ferris, Wei Shao, Stephen H. Hughes, W. Gregory Alvord, Andrew Cheng, Heather Joy Zar, Michael A. Parniak, Marshall W. Fordyce, Edwin DeJesus and Kirsten White. Their work appears in journals such as The Journal of Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Virology, Antimicrobial Agents and Chemotherapy and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact